Clinical Trials Sponsored by Shandong Lanjin Pharmaceuticals Co.,Ltd

Total 4058 results

Shandong Lanjin Pharmaceuticals Co.,Ltd

Unknown

Safety and Efficacy Study of Intracranially Implanted Carmustine to Treat Newly Diagnosed Malignant Glioma

Glioblastoma | Anaplastic Oligoastrocytoma | Anaplastic Astrocytoma | Anaplastic Oligodendroglioma

China
Shandong Lanjin Pharmaceuticals Co.,Ltd

Unknown

Safety and Efficacy Study of Bendamustine to Treat Non-Hodgkin Lymphoma

Non-Hodgkin Lymphoma by Clinical Course

China
Shandong Lanjin Pharmaceuticals Co.,Ltd

Unknown

Safety and Efficacy Study of Intracranially Implanted Carmustine to Treat Recurrent Malignant Glioma

Glioblastoma | Anaplastic Oligoastrocytoma | Anaplastic Astrocytoma | Anaplastic Oligodendroglioma

China
Shandong Lanjin Pharmaceuticals Co.,Ltd

Unknown

Safety and Efficacy Study of High Dose Melphalan to Treat Multiple Myeloma (MM)

Multiple Myeloma

China
Shandong Lanjin Pharmaceuticals Co.,Ltd

Unknown

Bendamustine Hydrochloride Injection for Previously Untreated Chronic Lymphocytic Leukemia (CLL)

Neoplasms | Leukemia | Chronic Lymphocytic Leukemia

China
Shandong Luye Pharmaceutical Co., Ltd.
Nanjing Sike Pharmaceutical Co., Ltd.

Completed

Pharmacokinetics Study of Liposomal Paclitaxel in Humans (LPS-PK-H)

Cancer

China
Shandong Luye Pharmaceutical Co., Ltd.

Unknown

Study of Huperzine A Sustained-Release Tablets in Patients With Alzheimer's Disease

Alzheimer's Disease

China
Shandong Luye Pharmaceutical Co., Ltd.

Unknown

A Clinical Trial of a Radiation Sensitizer in Radiochemotherapy for Thoracic Esophageal Squamous Carcinoma

Esophageal Carcinoma

China
Shandong Luye Pharmaceutical Co., Ltd.

Unknown

China Cimicifuga Trial of Climacteric Complaint Control (CCCCC)

Climacteric Symptoms

China
Shandong New Time Pharmaceutical Co., LTD

Recruiting

Efficacy and Safety Study of F520 Combined With Lenvatinib in the Treatment of Patients With Advanced Solid Tumors

Solid Tumors

China
Shandong New Time Pharmaceutical Co., LTD

Not yet recruiting

A Phase III Clinical Study of Minodronate Tablets in Postmenopausal Women With Osteoporosis

Osteoporosis

China
Shandong New Time Pharmaceutical Co., LTD

Not yet recruiting

Study of F527 in Patients With Relapsed or Refractory Lymphoma

Relapsed/Refractory Lymphoma

China
Shandong New Time Pharmaceutical Co., LTD

Completed

A Phase IV Study of Huazhi Rougan Granule in the Treatment of Non-alcoholic Simple Fatty Liver

Efficacy and Safety

China
Shandong New Time Pharmaceutical Co., LTD

Unknown

A Phase Ⅱ Study of F520 in Patients With Urothelial Carcinoma

Locally Advanced or Metastatic Urothelial Cell Carcinoma
Shandong New Time Pharmaceutical Co., LTD

Unknown

The Efficacy and Safety of F520 in Patients With Relapsed/Refractory Peripheral T Cell Lymphoma (PTCL).

Peripheral T Cell Lymphoma
Shandong New Time Pharmaceutical Co., LTD

Recruiting

Phase 1 Study of F182112 in Patients With Relapsed or Refractory Multiple Myeloma

Dose-Escalation Study, Relapsed or Refractory Multiple Myeloma

China
Shandong New Time Pharmaceutical Co., LTD

Completed

A Phase Ⅱ Study of F520 in Patients With Cervical Carcinoma

Cervical Cancer

China
Shandong New Time Pharmaceutical Co., LTD

Completed

Pharmacodynamic Equivalence Study Of Orlistat Capsules 60 mg

Bioequivalence

China
Shandong New Time Pharmaceutical Co., LTD

Unknown

A Study of F520 in Relapsed/Refractory Primary Central Nervous System Lymphoma (PCNSL) or Secondary Central Nervous System Lymphoma (SCNSL)

Primary Central Nervous System Lymphoma | Secondary Central Nervous System Lymphoma
Samjin Pharmaceutical Co., Ltd.

Completed

Clinical Study to Investigate the Efficacy and Safety of SJP002 Ophthalmic Solution in Patients With Dry Eye Syndrome.

Dry Eye Syndromes

Korea, Republic of
Samjin Pharmaceutical Co., Ltd.

Completed

A Phase 1 Clinical Study to Investigate the Pharmacokinetics and Safety/Tolerability of SA001 in Healthy Male Volunteers

Healthy

Korea, Republic of
Shandong New Time Pharmaceutical Co., LTD

Not yet recruiting

A Phase II Study of Rulonilimab Combined With Chemotherapy in the First-Line Treatment for Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

NSCLC | Non-small Cell Lung Cancer | PD-1

China
Shandong New Time Pharmaceutical Co., LTD

Recruiting

the Efficacy and Safety of Rulonilimab in Combination With Lenvatinib in Hepatocellular Carcinoma (HCC)

Hepatocellular Carcinoma

China
Shandong New Time Pharmaceutical Co., LTD

Not yet recruiting

A Phase II Study to Evaluate the Efficacy and Safety of F520 Combined With F007 in Patients With RR DLBCL

RR DLBCL; PD-1; CD20
Shandong New Time Pharmaceutical Co., LTD

Recruiting

A Study Comparing the Efficacy and Safety Between H-CHOP and R-CHOP in Untreated CD20-Positive Diffuse Large B-cell Lymphoma Patients

Recruiting

China
Shandong New Time Pharmaceutical Co., LTD

Completed

A Phase IV Study of Huazhi Rougan Granule

A Phase IV Trial to Investigate the Efficacy and Safety of Huazhi Rougan Granule in the Treatment of Non-alcoholic Simple Fatty Liver

China
Shandong New Time Pharmaceutical Co., LTD

Unknown

Phase Ⅰ Study to Evaluate the Safety and Tolerability of Using F520

Advanced Solid Tumor，Recurrent Solid Tumor，Lymphoma，Recurrent Lymphocyte Depleted Classical Hodgkin Lymphoma

China
Samjin Pharmaceutical Co., Ltd.

Completed

A Phase 4 Clinical Study to Investigate the Efficacy and Safety of Naloxone HCI IV in Patients With Stroke

Stroke, Acute

Korea, Republic of
Samjin Pharmaceutical Co., Ltd.

Completed

A phase4 Clinical Study to Evaluate the Safety and Efficacy of Switching to Tenofovir Disoproxil From Tenofovir Disoproxil Fumarate in Patients With Chronic Hepatitis B

Chronic Hepatitis B

Korea, Republic of
Samjin Pharmaceutical Co., Ltd.

Completed

Clinical Study to Investigate the Pharmacokinetics and Safety/Tolerability of SA001 in Healthy Male Volunteers

Healthy
Samjin Pharmaceutical Co., Ltd.

Completed

Clinical Study to Investigate the Efficacy and Safety of Orally Administered SA001 in Patients With Dry Eye Syndrome.

Dry Eye Syndrome

Korea, Republic of
Samjin Pharmaceutical Co., Ltd.

Completed

Clinical Study to Investigate the Efficacy of Orally Administered SA001 in Patients With Primary Sjögren's Syndrome

Primary Sjögren's Syndrome (pSS)

Korea, Republic of
Samjin Pharmaceutical Co., Ltd.

Completed

Clinical Study to Investigate the Systemic Exposure, Safety, and Local Tolerability of SJP002 Ophthalmic Solution in Healthy Male Volunteers

Healthy

Korea, Republic of
Samjin Pharmaceutical Co., Ltd.

Completed

Clinical Study to Evaluate the Safety and Efficacy of Switching to Tenofovir Disoproxil From Tenofovir Disoproxil Fumarate in Patients With Chronic Hepatitis B

Chronic Hepatitis b

Korea, Republic of
Shandong Luoxin Pharmaceutical Group Stock Co.,...

Active, not recruiting

Efficacy and Safety of Plecanatide Comparing With Placebo in the Treatment of Functional Constipation

Functional Constipation

China
Shandong Luoxin Pharmaceutical Group Stock Co.,...

Completed

A Phase I Study of LX-039 Tablets

Advanced Breast Cancer

China
Shandong Luoxin Pharmaceutical Group Stock Co.,...

Completed

A Multi-center, Randomized, Double-blind, Parallel-group, Placebo Controlled Phase III Study to Evaluate the Efficacy and Safety of LXI-15028 in Non-erosive Reflux Disease in Chinese Patients for 4 Weeks

Non-erosive Reflux Disease

China
Shandong Luoxin Pharmaceutical Group Stock Co.,...

Completed

A Phase I Study of LuoXin Innovate (LXI-15028) in Healthy Chinese Subjects to Evaluate the Pharmacokinetics, Safety and Tolerability.

Healthy

China
Shandong Simcere-Medgenn Bio-pharmaceutical Co....

Completed

Etoposide-Carboplatin Alone or With Endostar for Extensive Disease Small Cell Lung Cancer (ED-SCLC)

Small Cell Lung Cancer

China
Shandong Luoxin Pharmaceutical Group Stock Co.,...

Completed

Drug Interaction Study Between Tegoprazan, Bismuth, Amoxicillin and Clarithromycin

Healthy

China
Shandong Luoxin Pharmaceutical Group Stock Co.,...

Completed

Efficacy and Safety of LXI-15028 Comparing With Lansoprazole in the Treatment of Duodenal Ulcer

Duodenal Ulcer

China
Shandong Luoxin Pharmaceutical Group Stock Co.,...

Unknown

A Study of LXI-15029 in Patients With Advanced Malignant Solid Tumors

Advanced Breast Cancer

China
Shandong Luoxin Pharmaceutical Group Stock Co.,...

Completed

Efficacy and Safety of LXI-15028 Comparing With Esomeprazole in the Treatment of Erosive Esophagitis

Erosive Esophagitis (EE)

China
Shandong Simcere-Medgenn Bio-pharmaceutical Co....

Unknown

A Study of Endostar Combined With Chemotherapy for Treatment of Osteosarcoma

Osteosarcoma

China
Shandong Simcere-Medgenn Bio-pharmaceutical Co....

Completed

Paclitaxel Plus Carboplatin With or Without Endostar in Patients With Advanced Non-small Cell Lung Cancer

Advanced Non-small Cell Lung Cancer

China
Shandong Luoxin Pharmaceutical Group Stock Co.,...

Completed

Efficacy and Safety of Tegoprazan Versus Esomeprazole-containing Bismuth Quadruple Therapy for Eradication of Helicobacter Pylori

Helicobacter Pylori Infection

China
Shandong Luoxin Pharmaceutical Group Stock Co.,...

Completed

Mass Balance and Biotransformation Study of [14C]LXI-15028 in Humans

Healthy Subjects | Pharmacokinetics of 14C-labeled of LXI-15028

China
Nanjing Sanhome Pharmaceutical, Co., Ltd.

Recruiting

A Study to Investigate Safety and Tolerability of SH3809 Tablet in Patients With Advanced Solid Tumors

Advanced Solid Tumor

China
Nanjing Sanhome Pharmaceutical, Co., Ltd.

Unknown

Efficacy and Safety of SHC014748M in Patients With Relapsed or Refractory Follicular (FL) or Marginal Zone (MZL) Lymphoma

Follicular Lymphoma(FL) | Marginal Zone Lymphoma(MZL)

China
Nanjing Sanhome Pharmaceutical, Co., Ltd.

Unknown

A Study to Evaluate the Safety and Efficacy of SH-1028 in Locally Advanced or Metastatic NSCLC

Non-Small Cell Lung Cancer

3

Subscribe